Optimer Pharmaceuticals Inc (NASDAQ:OPTR.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products.

Recs

2
Player Avatar Ashelimited (76.49) Submitted: 9/23/2011 12:45:04 PM : Underperform Start Price: $16.31 OPTR.DL Score: +14.72

Pullback

Featured Broker Partners


Advertisement